Literature DB >> 17170417

Hypertriglyceridaemia in diabetes.

W Stuart A Smellie1.   

Abstract

Mild hypertriglyceridaemia is common in diabetes, but patients with newly presenting or poorly controlled diabetes may have a quantitatively different syndrome of gross hypertriglyceridaemia, which should be treated by optimising glycaemic control before use of lipid lowering drugs.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17170417      PMCID： PMC1702429          DOI： 10.1136/bmj.39043.398738.DE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


  9 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

Review 2.  Testing pitfalls and summary of guidance in lipid management.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2006-07-08

Review 3.  Best practice in primary care pathology: review 2.

Authors:  W S Smellie; J O Forth; C A M McNulty; L Hirschowitz; D Lilic; R Gosling; D Bareford; E Logan; K G Kerr; G P Spickett; J Hoffman; A Galloway; C A Bloxham
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

4.  A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care.

Authors:  W S Smellie; R Lowrie; E Wilkinson
Journal:  BMJ       Date:  2001-11-24

Review 5.  Triglyceride metabolism in diabetes mellitus.

Authors:  E A Nikkilä
Journal:  Prog Biochem Pharmacol       Date:  1973

6.  Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.

Authors:  G Mingrone; F L Henriksen; A V Greco; L N Krogh; E Capristo; A Gastaldelli; M Castagneto; E Ferrannini; G Gasbarrini; H Beck-Nielsen
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

7.  Clinical assessment of hyperlipidemic pancreatitis.

Authors:  M R Fortson; S N Freedman; P D Webster
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

8.  Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism.

Authors:  A Chait; J D Brunzell; J J Albers; W R Hazzard
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

9.  Detection of alcohol-induced fatty liver by computerized tomography.

Authors:  S L Allaway; C D Ritchie; D Robinson; T Seear; R Reznek; I K Fry; G R Thompson
Journal:  J R Soc Med       Date:  1988-03       Impact factor: 18.000
  9 in total
  5 in total

1.  Hypolipidaemic Effects of Gymnema sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar Rats.

Authors:  Dheeraj Kumar Singh; Narendra Kumar; Anjula Sachan; Preet Lakhani; Sachin Tutu; Rajendra Nath; Amod Kumar Sachan; Rakesh Kumar Dixit
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.

Authors:  Mihriye Mete; Charlton Wilson; Elisa T Lee; Angela Silverman; Marie Russell; Mario Stylianou; Jason G Umans; Wenyu Wang; Wm J Howard; Robert E Ratner; Barbara V Howard; Jerome L Fleg
Journal:  J Diabetes Complications       Date:  2011-07-19       Impact factor: 2.852

3.  Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients.

Authors:  Prabhavathi K; Kirthana Kunikullaya U; Jaisri Goturu
Journal:  J Clin Diagn Res       Date:  2014-02-03

Review 4.  Xanthelasma: An Update on Treatment Modalities.

Authors:  Zainab Laftah; Firas Al-Niaimi
Journal:  J Cutan Aesthet Surg       Date:  2018 Jan-Mar

5.  Extensive Giant Tuberous and Tendon Xanthomas in a 48-year-old Gentleman: A Case Report.

Authors:  Jagandeep S Virk; Divya Arora; Poonam Bhaker; Sumit Jain
Journal:  J Orthop Case Rep       Date:  2021-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.